The effect of Trp53 gene-dosage and parent-of-origin of inheritance on mouse gamete and embryo function in vitro

Biology of Reproduction

Volumn 86, Issue 6, 2012, Pages

  Li, A ^a   Ganeshan, L ^a   O'Neill, C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Embryo; Fertilization; Oocyte; P53; Sperm

Indexed keywords

PROTEIN P53; TRANSFORMATION RELATED PROTEIN 53; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLASTOCYST; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; FEMALE; FERTILIZATION; GAMETE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION REGULATION; GENOTYPE; HAPLOINSUFFICIENCY; IN VITRO STUDY; INHERITANCE; INNER CELL MASS; MALE; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SPERM; ALLELE; ANIMAL; C57BL MOUSE; GENETICS; OVULATION; PHYSIOLOGY; SPERMATOZOON;

MUS;

ALLELES; ANIMALS; EMBRYONIC DEVELOPMENT; FEMALE; FERTILIZATION; HAPLOINSUFFICIENCY; MALE; MICE; MICE, INBRED C57BL; OVULATION; SPERMATOZOA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863432417     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.097741     Document Type: Article

References (27)

1. Ford JM, Hanawalt PC. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc Natl Acad Sci U S A 1995; 92:8876-8880.
2. Dobyns WB. p53, guardian of the genome. Nature 1992; 358:15-16.
3. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-310.
4. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2:594-604.
5. Venkatachalam S, Shi Y-P, Jones SN, Vogel H, Bradley A, Pinkel D, Donehower LA. Retention of the wild-type p53 allele in tumors from p53-deficient mice: a reduction in p53 dosage is sufficient for cancer formation. EMBO J 1998; 17:4657-4667.
6. Venkatachalam S, Tyner SD, Pickering CR, Boley S, Recio L, French JE, Donehower LA. Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing. Toxicol Pathol 2001; 29:147-154.
7. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362:849-852.
8. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994; 9:1767-1773.
9. Gottlieb E, Haffner R, King A, Asher G, Gruss P, Lonai P, Oren M. Transgenic mouse model for studying the transcriptional activity of p53. EMBO J 1997; 16:1381-1390.
10. Jin XL, Chandrakanthan V, Morgan HD, O'Neill C. Preimplantation embryo development in the mouse requires the latency of TRP53 expression, which is induced by a ligand-activated PI3 kinase/AKT/ MDM2-mediated signaling pathway. Biol Reprod 2009; 80:286-294.
11. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000; 275:8945-8951.
12. Li A, Chandrakanthan V, Chami O, O'Neill C. Culture of zygotes increases TRP53 expression in B6 mouse embryos which reduces embryo viability. Biol Reprod 2007; 76:362-367.
13. Ganeshan L, Li A, O'Neill C. Transformation-related protein 53 expression in the early mouse embryo compromises preimplantation embryonic development by preventing the formation of a proliferating inner cell mass. Biol Reprod 2010; 83:958-964.
14. Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378:203-205.
15. O'Neill C. Evidence for the requirement of autocrine growth factors for development of mouse preimplantation embryos in vitro. Biol Reprod 1997; 56:229-237.
16. O'Neill C. The potential roles for embryotrophic ligands in preimplantation embryo development. Hum Reprod Update 2008; 14:275-288.
17. Aitken R, Roman S. Antioxidant systems and oxidative stress in the testes. Oxid Med Cell Longev 2008; 1:15-24.
18. Borrás C, Gómez-Cabrera M, Viña J. The dual role of p53: DNA protection and antioxidant. Free Radic Res 2011; 45:643-652.
19. Lech T, Golas A, Styrna J. Is p53 controlling spermatogenesis in male mice with the deletion on the Y chromosome? Zygote 2011; 12:1-6.
20. Marty MS, Singh NP, Holsapple MP, Gollapudi BB. Influence of p53 zygosity on select sperm parameters of the mouse. Mutat Res 1999; 427: 39-45.
21. Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 1995; 136:3665-3668.
22. Rucker EB, Dierisseau P, Wagner K-U, Garrett L, Wynshaw-Boris A, Flaws JA, Hennighausen L. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol 2000; 14:1038-1052.
23. Wells D, Bermudez MG, Steuerwald N, Malter HE, Thornhill AR, Cohen J. Association of abnormal morphology and altered gene expression in human preimplantation embryos. Fertil Steril 2005; 84:343-355.
24. Chandrakanthan V, Chami O, Stojanov T, O'Neill C. Variable expressivity of the tumour suppressor protein TRP53 in cryopreserved human blastocysts. Reprod Biol Endocrinol 2007; 5:39.
25. Feng Z, Zhang C, Kang H-J, Sun Y, Wang H, Naqvi A, Frank AK, Rosenwaks Z, Murphy ME, Levine AJ, Hu W. Regulation of female reproduction by p53 and its family members. FASEB J 2011; 25: 2245-2255.
26. Kang H-J, Feng Z, Sun Y, Atwal G, Murphy ME, Rebbeck TR, Rosenwaks Z, Levine AJ, Hu W. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proc Natl Acad Sci U S A 2009; 106:9761-9766.
27. Whibley C, Pharoah PDP, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer 2009; 9:95-107.